Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software
/PRNewswire/ -- Autonomous Healthcare today announced that the U.S. Food and Drug Administration (FDA) has granted the De Novo marketing authorization for...